News Release Detail
Mylan Nominates Rod Piatt to its Board of Directors
Mr. Piatt currently serves as the President and Owner of Horizon Properties, a real estate development company he founded in 1996. Mr. Piatt also holds a number of other business positions, including: Vice Chairman of Community Bank N.A., a publicly held company for which he also serves as Audit Committee Chairman; Director of Accutrex Products, Inc.; and Director and First Vice President of the Washington Industrial Development Corporation. From 1979 to 1996, he served as Vice-President and Director of Millcraft Industries, a multidimensional company primarily focused on the steel and real estate industries.
"Rod is a well-respected business leader and a prominent figure in southwestern Pennsylvania and brings to Mylan 30 years of experience across a variety of industries and also brings another strong independent voice to our Board. We look forward to working with him and benefiting from his substantial knowledge and leadership skills," stated Milan Puskar, Mylan Laboratories Chairman.
Mr. Piatt will be on the ballot for election at Mylan's Annual Shareholders Meeting on July 30, 2004. He would be elected to the Board seat vacated by John C. Gaisford, M.D., who will retire from the Mylan Board as of July 30. Dr. Gaisford, a renowned physician, has served on Mylan's Board for 12 years. Mylan appreciates the considerable experience and insight he has brought to the Company.
"Jack has been an instrumental board member whose wisdom and experience will be missed," said Mr. Puskar. "We thank him for his invaluable support and wish him the best."
Mylan Laboratories Inc. is a leading pharmaceutical company with four subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc., UDL Laboratories, Inc. and Mylan Bertek Pharmaceuticals Inc., that develop, manufacture and market an extensive line of generic and proprietary products.
For more information about Mylan, visit www.mylan.com .
SOURCE Mylan Laboratories Inc.
06/28/2004
CONTACT:
Heather Bresch (Media), +1-724-514-1800
Kris King (Investors),
+1-724-514-1800
both of Mylan Laboratories Inc.
Web site: http://www.mylan.com